Big pharma companies are organizing patient groups to lobby against proposals for drug companies in Europe to publish all of their data, including negative results and dangerous side-effects.  Lobbyists are targeting the European Medicines Agency (EMA), to prevent the agency’s push for all clinical study reports to be published, citing their concern that the published information might be misrepresented and cause health scares.

Read More